Psychiatry and Clinical Neurosciences

Cytokines and schizophrenia: Microglia hypothesis of schizophrenia
pp. 257-265(9)
Authors: Monji, Akira; Kato, Takahiro; Kanba, Shigenobu

Smaller amygdala is associated with anxiety in patients with panic disorder
pp. 266-276(11)
Authors: Hayano, Fumi; Nakamura, Motoaki; Asami, Takeshi; Uehara, Kumi; Yoshida, Takeshi; Roppongi, Tomohide; Otsuka, Tatsui; Inoue, Tomio; Hirayasu, Yoshio

Scale for measuring self-recoverability in daily life for people with schizophrenia
pp. 277-282(6)
Authors: Takamatsu, Toko; Hashimoto, Takeshi; Taira, Masaru; Fukutake, Masaaki; Maeda, Kiyoshi

Relationship between depressive mood and chronotype in healthy subjects
pp. 283-290(8)
Authors: Hidalgo, Maria Paz; Caumo, Wolnei; Posser, Michele; Coccaro, Sônia Beatriz; Camozzato, Ana Luiza; Chaves, Márcia Lorena Fagundes

Psychometric properties of the Japanese version of the Beck Cognitive Insight Scale: Relation of cognitive insight to clinical insight
pp. 291-297(7)
Authors: Uchida, Tomohiro; Matsumoto, Kazunori; Kikuchi, Akiko; Miyakoshi, Tetsuo; Ito, Fumiaki; Ueno, Takashi; Matsuoka, Hiroo

Plasma and cerebrospinal fluid substance P in post-stroke patients with depression
pp. 298-304(7)
Authors: Li, Ling; Gao, Xiaoya; Zhao, Jia; Ji, Xunming; Wei, Huan; Luo, Yumin

Thyroid hormones affect recovery from depression during antidepressant treatment
pp. 305-313(9)
Authors: Pae, Chi-Un; Mandelli, Laura; Han, Changsu; Ham, Byung-Joo; Masand, Prakash S.; Patkar, Ashwin A.; Steffens, David C.; De Ronchi, Diana; Serretti, Alessandro

Reliability and validity of a Japanese version of the Cambridge depersonalization scale as a screening instrument for depersonalization disorder
pp. 314-321(8)
Authors: Sugiura, Miyuki; Hirosawa, Masataka; Tanaka, Sumio; Nishi, Yasunobu; Yamada, Yasuyuki; Mizuno, Motoki

Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study
pp. 322-328(7)
Authors: Okugawa, Gaku; Kato, Masaki; Wakeno, Masataka; Koh, Jun; Morikawa, Masayuki; Matsumoto, Naoki; Shinosaki, Kazuhiro; Yoneda, Hiroshi; Kishimoto, Toshifumi; Kinoshita, Toshihiko

Medical and psychiatric comorbidity in psychiatric beds in general hospitals: A cross-sectional study in Tokyo
pp. 329-335(7)
Authors: Hatta, Kotaro; Nakamura, Hiroyuki; Usui, Chie; Kobayashi, Takafumi; Kamijo, Yoshito; Hirata, Toyoaki; Awata, Shuichi; Kishi, Yasuhiro; Arai, Heii; Kurosawa, Hisashi

Differentiation between attention-deficit/hyperactivity disorder and pervasive developmental disorders with hyperactivity on objective activity levels using actigraphs
pp. 336-343(8)
Authors: Tsujii, Noa; Okada, Akira; Kaku, Reigetsu; Kuriki, Noriko; Hanada, Kazushi; Shirakawa, Osamu

Association between feasibility of discharge, clinical state, and patient attitude among inpatients with schizophrenia in Japan
pp. 344-349(6)
Authors: Mino, Yoshio; Oshima, Iwao; Shimodera, Shinji

Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression
pp. 350-356(7)
Authors: Kaymak, Semra Ulusoy; Demir, Başaran; Oğuz, Kader Karlı; Şentürk, Senem; Uluğ, Berna

Multi-dimensional discriminative factors for Internet addiction among adolescents regarding gender and age
pp. 357-364(8)
Authors: Yen, Cheng-Fang; Ko, Chih-Hung; Yen, Ju-Yu; Chang, Yu-Ping; Cheng, Chung-Ping

A two-year follow-up study of chronic fatigue syndrome comorbid with psychiatric disorders
pp. 365-373(9)
Authors: Matsuda, Yasunori; Matsui, Tokuzo; Kataoka, Kouhei; Fukada, Ryosuke; Fukuda, Sanae; Kuratsune, Hirohiko; Tajima, Seiki; Yamaguti, Kouzi; Kato, Yukiko Hakariya; Kiriike, Nobuo

Neuropsychiatric symptoms predict change in quality of life of Alzheimer disease patients: A two-year follow-up study
pp. 374-384(11)
Authors: Tatsumi, Hiroshi; Nakaaki, Shutaro; Torii, Katsuyoshi; Shinagawa, Yoshihiro; Watanabe, Norio; Murata, Yoshie; Sato, Junko; Mimura, Masaru; Furukawa, Toshiaki A.

Risk factors for obstructive sleep apnea syndrome screening in mood disorder patients
pp. 385-391(7)
Authors: Hattori, Miho; Kitajima, Tsuyoshi; Mekata, Takahiro; Kanamori, Aya; Imamura, Mototaka; Sakakibara, Hiroki; Kayukawa, Yuhei; Okada, Tamotsu; Iwata, Nakao

Impact of psychiatric and medical comorbidity on cognitive function in depression
pp. 392-400(9)
Authors: Baune, Bernhard T.; McAfoose, Jordan; Leach, Geraldine; Quirk, Frances; Mitchell, David

Comorbidity of cardiovascular diseases with mood and anxiety disorder: A population based 4-year study
pp. 401-409(9)
Authors: Huang, Kai-Lin; Su, Tung-Ping; Chen, Tzeng-Ji; Chou, Yuan-Hwa; Bai, Ya-Mei

Relationship of intentional self-harm using sharp objects with depressive and dissociative tendencies in pre-adolescence-adolescence
pp. 410-416(7)
Authors: Sho, Noriko; Oiji, Arata; Konno, Chizue; Toyohara, Koji; Minami, Tatsuya; Arai, Takashi; Seike, Yoji

Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence
pp. 417-422(6)
Authors: Okahisa, Yuko; Ujike, Hiroshi; Kotaka, Tatsuya; Morita, Yukitaka; Kodama, Masafumi; Inada, Toshiya; Yamada, Mitsuhiko; Iwata, Nakao; Iyo, Masaomi; Sora, Ichiro; Ozaki, Norio; Kuroda, Shigetoshi

Attenuated prefrontal activation during a verbal fluency task in remitted major depression
pp. 423-425(3)
Authors: Okada, Go; Okamoto, Yasumasa; Yamashita, Hidehisa; Ueda, Kazutaka; Takami, Hiroshi; Yamawaki, Shigeto

Nonword repetition in schizophrenia: Semantic long-term memory supports phonological loop
pp. 426-426(1)

Isolated adrenocorticotropic hormone deficiency accompanied with delirium
pp. 426-427(2)

Dependence on quetiapine in combination with zolpidem and clonazepam in bipolar depression
pp. 427-428(2)

Paradoxical reactions to hypnotic agents in adolescents with free-running disorder
pp. 428-428(1)

Malignant catatonia accompanied by high urinary catecholamine levels mimicking the presentation of pheochromocytoma
pp. 428-429(2)

Antipsychotic-induced paroxysmal perceptual alteration in a patient with major depressive disorder
pp. 429-430(2)

Inclusion of thienodiazepines in prescription rate of anxiolytics
pp. 430-430(1)

Strict use of terminology: Reply to Dr Toda
pp. 430-431(2)